Almokalant
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H28N2O3S |
Molar mass | 352.49 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Almokalant is a drug used to treat arrhythmia.[1] It is a potassium channel blocker.[1] It has been found to have teratogenic effects in rats.[2]
See also
[edit]References
[edit]- ^ a b Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI (October 1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American Heart Journal. 126 (4): 1008–1011. doi:10.1016/0002-8703(93)90726-p. PMID 8213422.
- ^ Wellfelt K, Sköld AC, Wallin A, Danielsson BR (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species". Reproductive Toxicology. 13 (2): 93–101. doi:10.1016/s0890-6238(98)00066-5. PMID 10213516.